Related Experiment Video
Updated: May 14, 2026
09:11
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
[The significance for prognostic factor of pathological complete response (pCR) after neoadjuvant chemotherapy]
Dai Kitagawa1, Katsumasa Kuroi
1Division of Breast Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|January 29, 2013
Abstract
No abstract available in PubMed .